Table of Contents USA Diabetic Therapeutic Drugs Market Report 2012-2023 1 Diabetic Therapeutic Drugs Overview 1.1 Product Overview and Scope of Diabetic Therapeutic Drugs 1.2 Classification of Diabetic Therapeutic Drugs by Product Category 1.2.1 USA Diabetic Therapeutic Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 USA Diabetic Therapeutic Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 Insulin Therapies 1.2.4 Non-Insulin Therapies 1.3 USA Diabetic Therapeutic Drugs Market by Application/End Users 1.3.1 USA Diabetic Therapeutic Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Type 1 Diabetes 1.3.3 Type 2 Diabetes 1.3.4 Gestational Diabetes 1.4 USA Diabetic Therapeutic Drugs Market by Region 1.4.1 USA Diabetic Therapeutic Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Northeast Status and Prospect (2012-2023) 1.4.3 Midwest Status and Prospect (2012-2023) 1.4.4 South Status and Prospect (2012-2023) 1.4.5 West Status and Prospect (2012-2023) 1.5 USA Sales and Revenue ofSales and Revenue of Diabetic Therapeutic Drugs (2012-2023) 1.5.1 USA Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 USA Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Diabetic Therapeutic Drugs 2.2 Raw Material Analysis of Diabetic Therapeutic Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Diabetic Therapeutic Drugs 2.4 Other Costs Analysis of Diabetic Therapeutic Drugs 2.5 Manufacturing Cost Structure Analysis of Diabetic Therapeutic Drugs 2.6 Manufacturing Process Analysis of Diabetic Therapeutic Drugs 2.7 Raw Materials Sources of Diabetic Therapeutic Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 USA Diabetic Therapeutic Drugs Players/Suppliers Profiles and Sales Data 3.1 Pfizer 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Pfizer Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Pfizer Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.1.5 Pfizer Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.2 Novartis 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Novartis Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Novartis Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.2.5 Novartis Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.3 AstraZeneca 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 AstraZeneca Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 AstraZeneca Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.3.5 AstraZeneca Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.4 Eli Lilly 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Eli Lilly Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Eli Lilly Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.4.5 Eli Lilly Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.5 Merck 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Merck Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Merck Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.5.5 Merck Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.6 Novo Nordisk 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Novo Nordisk Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Novo Nordisk Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.6.5 Novo Nordisk Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.7 Sanofi 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Sanofi Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Sanofi Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.7.5 Sanofi Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.8 F. Hoffmann-La Roche 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 F. Hoffmann-La Roche Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.8.5 F. Hoffmann-La Roche Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.9 Takeda Pharmaceuticals 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Takeda Pharmaceuticals Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.9.5 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.10 Sun Pharma 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Sun Pharma Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Sun Pharma Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.10.5 Sun Pharma Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.11 Perle Biosciences 3.12 Arbutus Biopharma 3.13 Belrose Pharma 3.14 Mitsubishi Tanabe Pharma 3.15 Dong-A ST 4 USA Diabetic Therapeutic Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 USA Diabetic Therapeutic Drugs Market Competition by Players/Manufacturers 4.1.1 USA Diabetic Therapeutic Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 USA Diabetic Therapeutic Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 USA Diabetic Therapeutic Drugs Sales and Revenue by Type 4.2.1 USA Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 USA Diabetic Therapeutic Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 USA Diabetic Therapeutic Drugs Sales and Revenue by Application 4.3.1 USA Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 USA Diabetic Therapeutic Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 USA Diabetic Therapeutic Drugs Sales (K Units) by Application 5 Northeast Diabetic Therapeutic Drugs (Sales, Revenue and Price) 5.1 Northeast Diabetic Therapeutic Drugs Sales and Value (2012-2017) 5.1.1 Northeast Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Northeast Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 5.1.3 Northeast Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 Northeast Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 5.3 Northeast Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 6 Midwest Diabetic Therapeutic Drugs (Sales, Revenue and Price) 6.1 Midwest Diabetic Therapeutic Drugs Sales and Value (2012-2017) 6.1.1 Midwest Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 Midwest Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 6.1.3 Midwest Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 Midwest Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 6.3 Midwest Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 7 South Diabetic Therapeutic Drugs (Sales, Revenue and Price) 7.1 South Diabetic Therapeutic Drugs Sales and Value (2012-2017) 7.1.1 South Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 South Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 7.1.3 South Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 South Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 7.3 South Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 8 West Diabetic Therapeutic Drugs (Sales, Revenue and Price) 8.1 West Diabetic Therapeutic Drugs Sales and Value (2012-2017) 8.1.1 West Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 West Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 8.1.3 West Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 West Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 8.3 West Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Direct Marketing 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List 12 USA Diabetic Therapeutic Drugs Market Forecast (2018-2023) 12.1 USA Diabetic Therapeutic Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 12.1.1 USA Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 12.1.2 USA Diabetic Therapeutic Drugs Revenue and Growth Rate Forecast (2018-2023) 12.1.3 USA Diabetic Therapeutic Drugs Price and Trend Forecast (2018-2023) 12.2 USA Diabetic Therapeutic Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.1 USA Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 12.2.2 USA Diabetic Therapeutic Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.3 Northeast Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.4 Midwest Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.5 Midwest Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.6 West Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.3 USA Diabetic Therapeutic Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 12.3.1 USA Diabetic Therapeutic Drugs Sales Forecast by Type (2018-2023) 12.3.2 USA Diabetic Therapeutic Drugs Revenue Forecast by Type (2018-2023) 12.3.3 USA Diabetic Therapeutic Drugs Price Forecast by Type (2018-2023) 12.4 USA Diabetic Therapeutic Drugs Sales Forecast by Application (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer

List of Tables and Figures Figure USA Market Size (Million USD) Comparison 2012-2023 Table USA Market Diabetic Therapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table USA Diabetic Therapeutic Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table USA Diabetic Therapeutic Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Diabetic Therapeutic Drugs Table USA Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure USA Diabetic Therapeutic Drugs Sales (K Units) Market Share by Types in 2017 Figure Insulin Therapies Picture Figure Non-Insulin Therapies Picture Table USA Diabetic Therapeutic Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure USA Sales Market Share of Diabetic Therapeutic Drugs by Applications in 2017 Figure Type 1 Diabetes Examples Figure Type 2 Diabetes Examples Figure Gestational Diabetes Examples Table USA Market Diabetic Therapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure Northeast Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Midwest Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure South Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure West Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure USA Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) Figure USA Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Diabetic Therapeutic Drugs Table Industry News List of Diabetic Therapeutic Drugs Figure Industry Chain Structure of Diabetic Therapeutic Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Diabetic Therapeutic Drugs in 2017 Figure Manufacturing Process Analysis of Diabetic Therapeutic Drugs Table Raw Materials Sources of Diabetic Therapeutic Drugs Major Manufacturers in 2017 Table Major Buyers of Diabetic Therapeutic Drugs Table Pfizer Basic Information List Table Pfizer Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Pfizer Diabetic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Pfizer Diabetic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Diabetic Therapeutic Drugs Volume in and Its Application Share Table Pfizer Diabetic Therapeutic Drugs Volume in and Its Application Share Table Pfizer Diabetic Therapeutic Drugs Volume in and Its Application Share Table Novartis Basic Information List Table Novartis Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Novartis Diabetic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Novartis Diabetic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis Diabetic Therapeutic Drugs Volume in and Its Application Share Table Novartis Diabetic Therapeutic Drugs Volume in and Its Application Share Table Novartis Diabetic Therapeutic Drugs Volume in and Its Application Share Table AstraZeneca Basic Information List Table AstraZeneca Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AstraZeneca Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure AstraZeneca Diabetic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure AstraZeneca Diabetic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table AstraZeneca Diabetic Therapeutic Drugs Volume in and Its Application Share Table AstraZeneca Diabetic Therapeutic Drugs Volume in and Its Application Share Table AstraZeneca Diabetic Therapeutic Drugs Volume in and Its Application Share Table Eli Lilly Basic Information List Table Eli Lilly Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Eli Lilly Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Eli Lilly Diabetic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Eli Lilly Diabetic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Eli Lilly Diabetic Therapeutic Drugs Volume in and Its Application Share Table Eli Lilly Diabetic Therapeutic Drugs Volume in and Its Application Share Table Eli Lilly Diabetic Therapeutic Drugs Volume in and Its Application Share Table Merck Basic Information List Table Merck Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Merck Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Merck Diabetic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Merck Diabetic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Merck Diabetic Therapeutic Drugs Volume in and Its Application Share Table Merck Diabetic Therapeutic Drugs Volume in and Its Application Share Table Merck Diabetic Therapeutic Drugs Volume in and Its Application Share Table Novo Nordisk Basic Information List Table Novo Nordisk Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novo Nordisk Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Novo Nordisk Diabetic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Novo Nordisk Diabetic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novo Nordisk Diabetic Therapeutic Drugs Volume in and Its Application Share Table Novo Nordisk Diabetic Therapeutic Drugs Volume in and Its Application Share Table Novo Nordisk Diabetic Therapeutic Drugs Volume in and Its Application Share Table Sanofi Basic Information List Table Sanofi Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Sanofi Diabetic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Sanofi Diabetic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi Diabetic Therapeutic Drugs Volume in and Its Application Share Table Sanofi Diabetic Therapeutic Drugs Volume in and Its Application Share Table Sanofi Diabetic Therapeutic Drugs Volume in and Its Application Share Table F. Hoffmann-La Roche Basic Information List Table F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure F. Hoffmann-La Roche Diabetic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table F. Hoffmann-La Roche Diabetic Therapeutic Drugs Volume in and Its Application Share Table F. Hoffmann-La Roche Diabetic Therapeutic Drugs Volume in and Its Application Share Table F. Hoffmann-La Roche Diabetic Therapeutic Drugs Volume in and Its Application Share Table Takeda Pharmaceuticals Basic Information List Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Takeda Pharmaceuticals Diabetic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Volume in and Its Application Share Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Volume in and Its Application Share Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Volume in and Its Application Share Table Company Sun Pharma Basic Information List Table Company Sun Pharma Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Sun Pharma Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Company Sun Pharma Diabetic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Company Sun Pharma Diabetic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Sun Pharma Diabetic Therapeutic Drugs Volume in and Its Application Share Table Company Sun Pharma Diabetic Therapeutic Drugs Volume in and Its Application Share Table Company Sun Pharma Diabetic Therapeutic Drugs Volume in and Its Application Share Table USA Diabetic Therapeutic Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table USA Diabetic Therapeutic Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 USA Diabetic Therapeutic Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 USA Diabetic Therapeutic Drugs Sales Share by Players/Manufacturers Table USA Diabetic Therapeutic Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table USA Diabetic Therapeutic Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 USA Diabetic Therapeutic Drugs Revenue Market Share (%) Players Figure 2017 USA Diabetic Therapeutic Drugs Revenue Market Share (%) Players Table USA Diabetic Therapeutic Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table USA Diabetic Therapeutic Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of Diabetic Therapeutic Drugs by Type (2012-2017) Figure USA Diabetic Therapeutic Drugs Sales Growth Rate (%) by Type (2012-2017) Table USA Diabetic Therapeutic Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table USA Diabetic Therapeutic Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Diabetic Therapeutic Drugs by Type (2012-2017) Figure USA Diabetic Therapeutic Drugs Revenue Growth Rate by Type (2012-2017) Table USA Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table USA Diabetic Therapeutic Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of Diabetic Therapeutic Drugs by Regions (2012-2017) Figure USA Diabetic Therapeutic Drugs Sales Market Share by Regions in 2017 Table USA Diabetic Therapeutic Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table USA Diabetic Therapeutic Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Diabetic Therapeutic Drugs by Regions (2012-2017) Figure USA Diabetic Therapeutic Drugs Revenue Market Share by Regions in 2017 Table USA Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application (2012-2017) Table USA Diabetic Therapeutic Drugs Sales Share (%) by Application (2012-2017) Figure USA Diabetic Therapeutic Drugs Sales Market Share by Application (2012-2017) Figure USA Diabetic Therapeutic Drugs Sales Market Share by Application (2012-2017) Figure Northeast Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure Northeast Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northeast Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Northeast Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Northeast Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Northeast Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Northeast Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Northeast Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Northeast Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Midwest Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Midwest Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Midwest Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Midwest Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Midwest Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Midwest Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Midwest Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Midwest Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Midwest Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure South Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure South Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table South Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table South Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure South Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table South Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table South Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure South Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure West Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure West Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure West Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table West Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table West Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure West Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table West Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table West Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure West Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure USA Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure USA Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure USA Diabetic Therapeutic Drugs Price and Trend Forecast (2018-2023) Table USA Diabetic Therapeutic Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure USA Diabetic Therapeutic Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure USA Diabetic Therapeutic Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table USA Diabetic Therapeutic Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure USA Diabetic Therapeutic Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure USA Diabetic Therapeutic Drugs Revenue Market Share Forecast by Regions in 2023 Figure Northeast Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northeast Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure South Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure West Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure West Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table USA Diabetic Therapeutic Drugs Sales (K Units) Forecast by Type (2018-2023) Figure USA Diabetic Therapeutic Drugs Sales Market Share Forecast by Type (2018-2023) Table USA Diabetic Therapeutic Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure USA Diabetic Therapeutic Drugs Revenue Market Share Forecast by Type (2018-2023) Table USA Diabetic Therapeutic Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table USA Diabetic Therapeutic Drugs Sales (K Units) Forecast by Application (2018-2023) Figure USA Diabetic Therapeutic Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Pfizer Novartis AstraZeneca Eli Lilly Merck Novo Nordisk Sanofi F. Hoffmann-La Roche Takeda Pharmaceuticals Sun Pharma Perle Biosciences Arbutus Biopharma Belrose Pharma Mitsubishi Tanabe Pharma Dong-A ST